In most solid tumors, the percentages of tumor neovascular endothelium with positive PSMA typically exceed that of the tumor cells themselves, as is the case for primary brain tumors, lung cancer, breast cancer, gastrointestinal tumors, and renal cell carcinoma (RCC) (9, 11). Here, FOLH1 is linked to renal cell carcinoma.